Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
22.90
+0.73 (3.29%)
At close: Jun 10, 2026, 4:00 PM EDT
23.17
+0.27 (1.18%)
After-hours: Jun 10, 2026, 6:39 PM EDT

Privia Health Group Stock Forecast

Stock Price Forecast

According to 21 analysts polled by S&P Global, Privia Health Group stock has a consensus rating of "Strong Buy" and an average price target of $31.6. The average 1-year stock price forecast is 37.99% higher than the current stock price, while the lowest is $24 (+4.80%) and the highest is $40 (+74.67%).

Price Target: $31.6 (+37.99%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$24$31.6$31$40
Change+4.80%+37.99%+35.37%+74.67%

Analyst Ratings

The average analyst rating for Privia Health Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy141314141414
Buy555555
Hold222222
Sell000000
Strong Sell000000
Total212021212121

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Truist Financial
Truist Financial
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 28, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$34
BuyMaintains$34+48.47%May 28, 2026
Barclays
Barclays
Hold
Maintains
$25$24
HoldMaintains$25$24+4.80%May 26, 2026
Citi
Citi
Buy
Maintains
$32
BuyMaintains$32+39.74%May 14, 2026
TD Cowen
TD Cowen
Buy
Maintains
$30
BuyMaintains$30+31.00%May 11, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
2.43B
from 2.12B
Increased by 14.33%
Revenue Next Year
2.67B
from 2.43B
Increased by 9.84%
EPS This Year
0.94
from 0.99
Decreased by -4.68%
EPS Next Year
1.09
from 0.94
Increased by 15.42%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
966.22M1.36B1.66B1.74B2.12B2.43B
Revenue Growth
18.25%40.41%22.19%4.75%22.26%14.33%
Gross Profit
63.66M134.78M161.50M176.85M209.43M523.30M
Gross Margin
6.59%9.93%9.74%10.19%9.87%21.56%
Operating Income
-217.44M-19.12M20.65M16.98M34.24M45.63M
Net Income
-188.23M-8.59M23.08M14.39M22.92M34.58M
EPS
----0.990.94
EPS Growth
----26.92%-4.68%
Forward PE
--93.7380.5291.7224.27
Free Cash Flow
139.02M57.36M71.86M104.86M134.46M129.09M
No. Analysts
-----16
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High2.5B
Avg2.4B
Low2.4B

Revenue Growth

Revenue Growth202620272028
High
18.1%
Avg
14.3%
Low
12.1%

EPS Forecast

EPS202620272028
High1.20
Avg0.94
Low0.74

EPS Growth

EPS Growth202620272028
High
21.2%
Avg
-4.7%
Low
-25.3%